Ammonia (13N) (ammonia with radioisotope nitrogen-13) is a medication for diagnostic positron emission tomography (PET) imaging of the myocardium.[1][2][3]
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | H3[13N] |
| 3D model (JSmol) | |
| |
| |
References
edit- ^ a b "Ammonia N 13- nh3n13 injection". DailyMed. 30 October 2019. Retrieved 15 September 2020.
- ^ Cheng KT (December 2007). "[13N] Ammonia". Molecular Imaging and Contrast Agent Database. National Center for Biotechnology Information. PMID 20641280.
- ^ Albano D, Giubbini R, Bertagna F (December 2019). "13N-NH3 PET/CT in oncological disease". Japanese Journal of Radiology. 37 (12): 799–807. doi:10.1007/s11604-019-00883-7. PMID 31599383. S2CID 203986838.
External links
edit- "Ammonia N 13". Drug Information Portal. U.S. National Library of Medicine.
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |